Cambridge Precision Ltd has been contributing to a collaboration of scientists, engineers, academics and business people exploring technologies to improve medical treatments in lower income countries, specifically Oxygen treatments.
David Fairen-Jimenez, Reader in Molecular Engineering at the Dept. of Chemical Engineering and Biotechnology, University of Cambridge and one of the leading lights in this collaboration, has published an article which examines why getting access to pure oxygen for medical treatments is a complicated, expensive and often very dangerous business.
“People might once have considered oxygen a human right. But the pandemic has revealed that access to oxygen – in a pure form, for medical use – is a luxury in most low and middle-income countries”. You can read the article here in full.
CPL continue to support and collaborate with this initiative.
